ERBB2 and breast carcinoma: There are different methods available to evaluate ERBB2 status [21], although immunohistochemistry (IHC; for protein overexpression) and fluorescence in situ hybridization (FISH; for gene amplification) offer several advantages, because the aberration can be evaluated directly in malignant cells taken from archival breast cancer specimens.